126 related articles for article (PubMed ID: 23261493)
21. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.
Hill KP; Palastro MD; Gruber SA; Fitzmaurice GM; Greenfield SF; Lukas SE; Weiss RD
Am J Addict; 2017 Dec; 26(8):795-801. PubMed ID: 28921814
[TBL] [Abstract][Full Text] [Related]
22. Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence.
Peters EN; Hughes JR
Drug Alcohol Depend; 2010 Jan; 106(2-3):111-8. PubMed ID: 19783385
[TBL] [Abstract][Full Text] [Related]
23. Cue-induced craving for marijuana in cannabis-dependent adults.
Lundahl LH; Johanson CE
Exp Clin Psychopharmacol; 2011 Jun; 19(3):224-30. PubMed ID: 21480734
[TBL] [Abstract][Full Text] [Related]
24. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
[TBL] [Abstract][Full Text] [Related]
26. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.
Mason BJ; Crean R; Goodell V; Light JM; Quello S; Shadan F; Buffkins K; Kyle M; Adusumalli M; Begovic A; Rao S
Neuropsychopharmacology; 2012 Jun; 37(7):1689-98. PubMed ID: 22373942
[TBL] [Abstract][Full Text] [Related]
27. [Development and validation of an overall instrument to measure craving across multiple substances: the Mannheimer Craving Scale (MaCS)].
Nakovics H; Diehl A; Geiselhart H; Mann K
Psychiatr Prax; 2009 Mar; 36(2):72-8. PubMed ID: 18924060
[TBL] [Abstract][Full Text] [Related]
28. What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt.
Piper ME; Vasilenko SA; Cook JW; Lanza ST
Addiction; 2017 Feb; 112(2):330-339. PubMed ID: 27633341
[TBL] [Abstract][Full Text] [Related]
29. The cost-effectiveness of four treatments for marijuana dependence.
Olmstead TA; Sindelar JL; Easton CJ; Carroll KM
Addiction; 2007 Sep; 102(9):1443-53. PubMed ID: 17645430
[TBL] [Abstract][Full Text] [Related]
30. N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study.
Cullen KR; Klimes-Dougan B; Westlund Schreiner M; Carstedt P; Marka N; Nelson K; Miller MJ; Reigstad K; Westervelt A; Gunlicks-Stoessel M; Eberly LE
J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):136-144. PubMed ID: 29053023
[TBL] [Abstract][Full Text] [Related]
31. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users.
Wesley MJ; Westgate PM; Stoops WW; Kelly TH; Hays LR; Lile JA
Exp Clin Psychopharmacol; 2018 Jun; 26(3):310-319. PubMed ID: 29863387
[TBL] [Abstract][Full Text] [Related]
32. Nefazodone decreases anxiety during marijuana withdrawal in humans.
Haney M; Hart CL; Ward AS; Foltin RW
Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
[TBL] [Abstract][Full Text] [Related]
33. Validation of the French version of the marijuana craving questionnaire (MCQ) generates a two-factor model.
Chauchard E; Goutaudier N; Heishman SJ; Gorelick DA; Chabrol H
Am J Drug Alcohol Abuse; 2015 Jan; 41(1):82-7. PubMed ID: 25490609
[TBL] [Abstract][Full Text] [Related]
34. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
Cooper ZD; Foltin RW; Hart CL; Vosburg SK; Comer SD; Haney M
Addict Biol; 2013 Nov; 18(6):993-1002. PubMed ID: 22741619
[TBL] [Abstract][Full Text] [Related]
35. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
[TBL] [Abstract][Full Text] [Related]
36. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study.
Prado E; Maes M; Piccoli LG; Baracat M; Barbosa DS; Franco O; Dodd S; Berk M; Vargas Nunes SO
Redox Rep; 2015 Sep; 20(5):215-22. PubMed ID: 25729878
[TBL] [Abstract][Full Text] [Related]
37. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
[TBL] [Abstract][Full Text] [Related]
38. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
McRae-Clark AL; Baker NL; Gray KM; Killeen TK; Wagner AM; Brady KT; DeVane CL; Norton J
Drug Alcohol Depend; 2015 Nov; 156():29-37. PubMed ID: 26386827
[TBL] [Abstract][Full Text] [Related]
39. Craving is associated with amygdala volumes in adolescent marijuana users during abstinence.
Padula CB; McQueeny T; Lisdahl KM; Price JS; Tapert SF
Am J Drug Alcohol Abuse; 2015 Mar; 41(2):127-32. PubMed ID: 25668330
[TBL] [Abstract][Full Text] [Related]
40. Conditioned "Cross Fading": The Incentive Motivational Effects of Mediated-Polysubstance Pairings on Alcohol, Marijuana, and Junk Food Craving.
Clayton RB; Bailey RL; Liu J
J Health Commun; 2019; 24(3):319-327. PubMed ID: 30963814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
